Can physical assessment techniques aid diagnosis in people with chronic fatigue syndrome/myalgic encephalomyelitis? A diagnostic accuracy study. by Hives, L et al.
 1Hives L, et al. BMJ Open 2017;7:e017521. doi:10.1136/bmjopen-2017-017521
Open Access 
AbstrAct
Objective To assess five physical signs to see whether 
they can assist in the screening of patients with chronic 
fatigue syndrome/myalgic encephalomyelitis (CFS/ME) and 
potentially lead to quicker treatment.
Methods This was a diagnostic accuracy study 
with inter-rater agreement assessment. Participants 
recruited from two National Health Service hospitals, 
local CFS/ME support groups and the community were 
examined by three practitioners on the same day in 
a randomised order. Two allied health professionals 
(AHPs) performed independent examinations of physical 
signs including: postural/mechanical disturbances of 
the thoracic spine, breast varicosities, tender Perrin’s 
point, tender coeliac plexus and dampened cranial flow. 
A physician conducted a standard clinical neurological 
and rheumatological assessment while looking for 
patterns of illness behaviour. Each examination lasted 
approximately 20 min.
results Ninety-four participants were assessed, 52 
patients with CFS/ME and 42 non-CFS/ME controls, 
aged 18–60. Cohen’s kappa revealed that agreement 
between the AHPs was substantial for presence of the 
tender coeliac plexus (κ=0.65, p<0.001) and moderate 
for postural/mechanical disturbance of the thoracic 
spine (κ=0.57, p<0.001) and Perrin’s point (κ=0.56, 
p<0.001). A McNemar’s test found no statistically 
significant bias in the diagnosis by the experienced 
AHP relative to actual diagnosis (p=1.0) and a 
marginally non-significant bias by the newly trained 
AHP (p=0.052). There was, however, a significant bias 
in the diagnosis made by the physician relative to 
actual diagnosis (p<0.001), indicating poor diagnostic 
utility of the clinical neurological and rheumatological 
assessment.
conclusions Using the physical signs appears to 
improve the accuracy of identifying people with CFS/
ME and shows agreement with current diagnostic 
techniques. However, the present study concludes that 
only two of these may be needed. Examining for physical 
signs is both quick and simple for the AHP and may be 
used as an efficient screening tool for CFS/ME. This 
is a small single-centre study, and therefore, further 
validation in other centres and larger populations is 
needed.
IntrOductIOn
Chronic fatigue syndrome/myalgic enceph-
alomyelitis (CFS/ME) is characterised by 
severe, debilitating fatigue that is exacer-
bated by exercise but does not improve with 
rest. This condition can lead to a substan-
tial impairment, making every day activities 
difficult. There is currently no universally 
accepted method of diagnosing CFS/ME, so 
other conditions with a similar presentation 
of symptoms must first be ruled out. There-
fore, the diagnosis of CFS/ME can often be a 
long process.
Up until recently, the most widely accepted 
criteria for CFS/ME was the revised US 
Centers for Disease Control and Prevention 
(CDC) definition,1 which required at least a 
6-month period of fatigue that significantly 
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strengths and limitations of this study
 ► This is the first study that explores agreement on 
the presence of physical signs in the screening of 
patients with chronic fatigue syndrome/myalgic 
encephalomyelitis (CFS/ME) and demonstrates proof 
of concept of these signs.
 ► This study did not assess the performance of 
physical signs in diagnosing CFS/ME among people 
reporting with illness in clinical practice.
 ► The screening method did not involve patient/family 
history, patient symptoms or any discussion between 
practitioner and patient; including these would be 
likely to increase accuracy in clinical practice.
 ► There were more female participants than males, at 
a rate similar to other studies, which have found a 
higher prevalence of CFS/ME in females; however, 
there were similar percentages of males and 
females among the controls.
 ► This was a small study that included only two allied 
health professionals using the Perrin technique and 
did not include participants with severe CFS/ME; this 
limits the generalisation of the findings.
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interferes with a person’s everyday activities. In addition 
to this, four or more of the following symptoms must have 
persisted or reoccurred within the last 6 months; impaired 
memory or concentration, postexertion malaise, sore 
throat, tender lymph nodes, aching or stiff muscles, joint 
pain, headache and unrefreshing sleep. The latest inter-
nationally recognised diagnostic criteria for CFS/ME is 
the International Consensus Criteria2 based on the widely 
adopted Canadian Criteria.3
The Canadian criteria included many of the cardiopul-
monary and neurological abnormalities, which were not 
included in the CDC criteria. In addition, the Canadian 
criteria selected cases with less psychiatric comorbidity, 
more physical functional impairment, more fatigue/
weakness, plus neurological symptoms, which were signifi-
cantly different from psychiatric controls with CFS/ME.4 
However, in the UK, The National Institute for Health 
and Care Excellence (NICE) recognises the heteroge-
neity of the condition, advising that diagnosis of CFS/ME 
should be made after other possible diagnoses have been 
excluded and the symptoms have persisted for at least 
4 months. The NICE guidance also states that diagnosis 
should be reassessed if none of the following key features 
of the disorder are present: postexertional fatigue, cogni-
tive difficulties, sleep problems or chronic pain.5
Due to the heterogeneity of the disorder, the aeti-
ology of CFS/ME remains unknown with many theo-
ries surrounding the pathophysiology of the disorder.6 
The literature suggests that a range of possible causes 
including hormonal disturbances, immune system 
dysfunction, infectious and viral agents and nervous 
system abnormalities may all play a role in the patho-
physiology of the disease.7 Early research suggested that 
infectious agents such as the Epstein-Barr virus (EBV) 
are associated with CFS/ME, with a persisting EBV infec-
tion being seen in those with the condition.8 A number 
of other infectious agents have been linked to the onset 
of CFS/ME including enteroviruses, which could explain 
the gastrointestinal symptoms often seen in patients,9 and 
also the acute B19 virus infection.10 It has been suggested 
that viral infections can alter immune response, which in 
turn can chronically activate the immune system11 and 
lead to many of the symptoms associated with CFS/ME. 
However, the research within this field is inconsistent with 
no evidence of a single infection causing CFS/ME, as well 
as many patients showing no sign of previous infection,12 
suggesting that infectious agents may only be relevant to 
a subset of the patient population.
Lymphatic system alterations are suggested to have 
involvement in CFS/ME with dysfunction within the 
immune system, causing toxic build up within the central 
nervous system (CNS) and leading to engorgement 
of varicose lymph vessels that can be felt on examina-
tion.13 Tender lymph nodes are included in the ICC, 
Canadian and US CDC definitions1 and the NICE guid-
ance,5 confirming it is a common symptom of the disorder 
related to immune system abnormalities. Techniques to 
target these engorgements and stimulate the drainage of 
toxins in the lymph nodes have been shown to lead to 
symptom improvement in patients with CFS/ME.13
Currently, there is no definitive way of diagnosing 
patients, although recent research has suggested that 
there is a link between CFS/ME, the lymphatic drainage 
system and the CNS and that, in fact, patients with CFS/
ME have certain physical signs present that may explain 
a number of the characteristics of the condition.13 The 
Perrin technique is a system of manual diagnosis and 
treatment that is based on the hypothesis that CFS/ME 
is a disorder of the lymphatic drainage of the CNS, which 
leads to five physical signs.14
The first aim of this study was to see whether the five 
physical signs of the Perrin technique can assist in the 
screening of patients with CFS/ME, which could then 
subsequently lead to quicker treatment. Second, the study 
aimed to see whether the diagnostic accuracy was similar 
for a newly trained allied health professional (AHP) with 
no prior experience of CFS/ME compared with an expe-
rienced AHP.
MethOds
This was a diagnostic accuracy study with inter-rater agree-
ment assessment. R&D approval was obtained from each 
participating NHS Trust. The full study protocol has been 
made available at the same publisher.
recruitment
Participants with CFS/ME were recruited from two 
hospital clinics and local support groups within the 
North West. Social media and posters displayed around 
the University of Central Lancashire were used to adver-
tise the study. Healthy participants were recruited from 
non-blood relatives and friends of people with CFS/ME, 
staff and students from the university and from those who 
had heard about the study over social media. All partici-
pants voluntarily contacted the research team, by email, 
telephone or post, to register their interest.
Those who contacted the researcher were sent a partici-
pant information sheet via email or post. Potential partic-
ipants were given time to consider participation, during 
which they could contact the researcher to ask any ques-
tions about the research. The researcher then sent out a 
consent form to each person, which were then returned 
if they were happy to take part.
Participant eligibility
On receiving their completed consent form, the 
researcher contacted each person by telephone in order 
to assess their eligibility to take part in the study. Poten-
tial participants who were aged between 18 and 60 were 
assessed using two forms: a recruitment screening form 
based on the NICE guidance5 and a form based on the 
International Consensus Criteria2 (reference standard). 
These eligibility criteria were used to ensure that each 
patient with CFS/ME had received a correct diagnosis of 
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CFS/ME and to ensure that control participants did not 
have undiagnosed CFS/ME.
Inclusion criteria for cFs/Me group
To be included, patients with CFS/ME needed to have a 
prior formal diagnosis of CFS/ME5 at a National Health 
Service (NHS) hospital specialised clinic, persistent or 
recurrent fatigue for at least the past 6 months, a clear 
starting point to the fatigue, the fatigue should be unex-
plained by any other conditions, the fatigue should 
reduce the amount of physical activity each person could 
do and the fatigue should feel worse after physical activity.
Additionally, patients with CFS/ME needed to have at 
least one of the following symptoms: difficulty sleeping or 
insomnia, joint pain without swelling, headaches, painful 
lymph nodes that are not enlarged, recurrent sore throats, 
muscle pain without swelling, poor mental function (eg, 
difficulty thinking), symptoms getting worse after phys-
ical or mental exertion, feeling unwell or having flu-like 
symptoms, dizziness or nausea or heart palpitations.
exclusion criteria for both cFs/Me and control groups
The following were excluded from taking part: people 
needing to use a wheelchair and pregnant and lactating 
women. In addition: comorbidities including: anae-
mias, autoimmune diseases, cardiac disease, endocrine 
disorders, infectious diseases, intestinal diseases, malig-
nancies, neurological disorders, primary psychiatric disor-
ders, significant pulmonary disease and primary sleep 
disorders. Additional exclusion criteria for control group 
included: a diagnosis of CFS/ME or a family history of 
CFS/ME.
Each participant was allocated a participant ID number 
with the clinical team being blinded to the groupings.
Assessment methods
Perrin technique
The examination comprised the following four 
assessments:
A. Participant standing: observation and palpation of 
thoracic spine for any postural defects; regions of red-
ness, temperature change or skin rashes or eruptions, 
for example, acne/boils.
B. Participant lying supine: observation and palpation of 
breast tissue for varicosities in the surface lymphatics 
and abnormal breast tenderness at ‘Perrin’s point’, 
which is a superficial tender area found at around 
2–3 cm lateral and superior to the left nipple.15
C. With the participant remaining supine, palpation of 
the region of the coeliac plexus just below the xiphoid 
in the upper central area of the abdomen for any ab-
normal tenderness with possible temperature change 
in the region.
D. With the participant remaining in a supine position, 
cradle the head and examine the quality of the cranial 
rhythmic impulse.16
These assessments resulted in identification of the 
following signs as present or not present: (1) postural/
mechanical disturbances of the thoracic spine (assess-
ment A); (2) breast varicosities (assessment B); (3) tender 
Perrin’s point (assessment B); (4) tender coeliac plexus 
(assessment C); and (5) dampened cranial flow (assess-
ment D).
If all five signs were present, then the participant is 
classified as having CFS/ME. If one or more of the signs 
was absent, then the participant is classified as not having 
CFS/ME.16
The examination was performed by two AHPs. One had 
10 years of experience of using the Perrin technique and 
working with patients with CFS/ME (experienced AHP); 
the other was newly trained in the Perrin technique with 
no prior experience of CFS/ME (newly trained AHP). 
The newly trained AHP received training, especially for 
this study, which involved being taught how to examine 
patients for the five physical signs and having hand-on 
experience of practising the technique.
Rheumatological assessment
A standard clinical neurological and rheumatological 
assessment was performed by a physician while observing 
the participant for any signs of illness behaviour, but no 
clinical history was taken. The neurological examination 
included muscle strength testing, examination of muscle 
tone in arms and legs, coordination including the finger 
nose test, heel-shin test, heel-toe walking, reflexes and 
sensation with eyes closed. The rheumatological examina-
tion examined joint swelling, wasting of regional muscles, 
deformity of joint, redness in joints or tendons and the 
palpation of the margin of joints in hands and feet.
If all the tests were normal with no observed illness 
behaviour, the patient was classified as not having CFS/
ME, whereas if abnormal observations were made, the 
physician used their clinical experience to decide if the 
participant had CFS/ME. The physician performing 
these assessments had experience of working in NHS 
clinics for CFS/ME but had no experience of the Perrin 
technique (physician).
Data collection
For each participant, all data collection was performed 
on a single assessment day. They were allowed to bring 
a friend or relative along for support or, if requested, a 
chaperone was provided by the research team. Partic-
ipants were rebriefed on what would be involved, and 
consent was confirmed.
Each of the participants were separately examined by 
the three practitioners in different rooms. The order 
of examinations was randomised. No conversation took 
place between the participants and practitioners except 
to determine if there was any pain or tenderness in 
certain regions.
Data analysis
A priori, the Perrin technique required all five symptoms 
to be present for a patient to be diagnosed as CFS/ME. 
Using this criterion, the sensitivity and specificity of the 
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Table 1 Gender balance of the two groups
CFS/ME Control
Male 9 (17%) 25 (60%)
Female 43 (83%) 17 (40%)
CFS/ME, chronic fatigue syndrome/myalgic encephalomyelitis.
Table 2 Diagnostic performance of the three practitioners
Practitioner
True 
positives
False 
negatives
False 
positives
True 
negatives Sensitivity Specificity
Positive 
predictive 
value
Negative 
predictive 
value
Accuracy 
(%)
Experienced AHP 46 6 7 35 0.88 0.83 0.87 0.85 86.2
Newly trained AHP 36 16 6 36 0.69 0.86 0.86 0.69 76.6
Physician 23 29 0 42 0.44 1.00 1.00 0.57 69.1
AHP, allied health professional.
diagnosis of CFS/ME relative to the reference standard 
were estimated as simple proportions, accompanied by 
exact (binomial) 95% CIs. McNemar’s test was used to 
investigate whether any of the practitioners systematically 
underdiagnosed or overdiagnosed CFS/ME. Agreement 
in the diagnosis of CFS/ME between AHPs using the 
Perrin technique was estimated using Cohen’s kappa (κ) 
coefficient; an approximate 95% CI for κ was obtained 
using bias-corrected non-parametric bootstrapping. 
Agreement between their identification of the individual 
physical signs was also estimated using the same methods.
Exploratory analysis of the performance of using 
different numbers of symptoms was then performed. 
Symptoms were removed based on the observed agree-
ment between AHPs; thus, the four-symptom test excluded 
the symptom with lowest agreement, the three-symptom 
test excluded the two symptoms with the two lowest agree-
ments and so on.
Sample size
The target sample size was 50 with CFS/ME and 50 
controls to enable estimation of sensitivity and speci-
ficity of each Perrin technique AHP’s diagnosis of CFS/
ME (relative to the imperfect reference standard) to 
within ±9.9% with 95% confidence if the sensitivity and 
specificity were each at least 85%. It would also enable the 
estimation of κ (for inter-rater agreement between each 
pair), with 95% confidence, to within ±0.140 providing κ 
were at least 0.7.
results
Ninety-four participants were recruited: 52 patients with 
CFS/ME and 42 non-CFS/ME controls. The gender ratio 
in the CFS/ME group (shown in table 1) is in keeping 
with epidemiological studies, which have shown a larger 
number of patients with CFS/ME to be female with a 
ratio of 2:1 or more.17 Results show that, on average, the 
experienced AHP was most accurate (86%) at correctly 
diagnosing participants. This was followed by the newly 
trained who correctly diagnosed 77% and the physician 
who correctly diagnosed 69% of participants.
sensitivity and specificity
Table 2 shows the prevalence, sensitivity (the proportion 
of positive results in people with CFS/ME), specificity 
(the proportion of negative CFS/ME results in healthy 
controls), positive predictor value (the proportion with 
CFS/ME in participants with a positive result) and nega-
tive predictive value (the proportion of healthy controls 
with negative CFS/ME results).
When using the five physical signs of the Perrin tech-
nique, the sensitivity for the experienced AHP was 0.88 
(95% CI 0.77 to 0.96) and the specificity was 0.83 (95% 
CI 0.69 to 0.93). Similarly, when the newly trained AHP 
used the same technique, the specificity was 0.86 (95% 
CI 0.71 to 0.95); however, sensitivity was lowered to 0.69 
(95% CI 0.55 to 0.81). This shows that although using the 
same technique, the newly trained AHP struggled more 
frequently to identify correctly all five physical signs in 
people with a positive diagnosis of CFS/ME. There was no 
statistically significant bias in the diagnosis by the expe-
rienced AHP relative to actual diagnosis (p=1.0). There 
was also a marginally non-significant evidence of biased 
diagnosis by the newly trained AHP relative to actual 
diagnosis (p=0.052), potentially favouring a non-CFS/ME 
diagnosis.
When using the standard clinical neurological and 
rheumatological examination, the sensitivity of the physi-
cian was 0.44 (95% CI 0.30 to 0.59) and the specificity 
was 1.0 (95% CI 0.92 to 1.0). These results show that 
while able to identify correctly all healthy controls, the 
physician struggled the most out of all three practitioners 
to identify correctly people with a positive diagnosis of 
CFS/ME. There was a significant bias in the diagnosis by 
the physician relative to actual diagnosis (p<0.001), also 
favouring a non-CFS diagnosis.
Agreement between the experienced and newly trained AhPs
There was moderate agreement between the experi-
enced and newly trained AHPs on overall diagnosis 
using the five physical signs of the Perrin technique 
(κ=0.56, 95% CI 0.40 to 0.72, p<0.001). Regarding the 
identification of the individual physical signs, there was 
substantial agreement between the AHPs on the pres-
ence of the tender coeliac plexus (κ=0.65; 95% CI 0.48 
to 0.80, p<0.001) and agreement was moderate both on 
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Table 3 Experienced allied health professional
Items (n)
True 
positives
False 
positives
True 
negatives
False 
negatives Sensitivity Specificity
Positive 
predictive 
value
Negative 
predictive 
value
Accuracy
(%)
5* 46 7 35 6 0.88 0.83 0.87 0.85 86.2
4* 46 7 35 6 0.88 0.83 0.87 0.85 86.2
3* 46 7 35 6 0.88 0.83 0.87 0.85 86.2
2* 48 7 35 4 0.92 0.83 0.87 0.90 88.3
1* 49 12 30 3 0.94 0.71 0.80 0.91 84.0
5* includes all 5 Perrin technique physical signs; 4* includes postural/mechanical disturbances of the thoracic spine, tender Perrin’s point, 
tender coeliac plexus and dampened cranial flow; 3* includes postural/mechanical disturbances of the thoracic spine, tender Perrin’s 
point and tender coeliac plexus; 2* includes tender coeliac plexus and postural/mechanical disturbance of the thoracic spine; and 1* includes 
tender coeliac plexus.
Table 4 Newly trained allied health professional
Items (n)
True 
positives
False 
positives
True 
negatives
False 
negatives Sensitivity Specificity
Positive 
predictive value
Negative 
predictive value
Accuracy
(%)
5* 36 6 36 16 0.69 0.86 0.86 0.69 76.6
4* 36 7 35 16 0.69 0.83 0.84 0.69 75.5
3* 40 7 35 12 0.77 0.83 0.85 0.74 79.8
2* 42 8 34 10 0.81 0.81 0.84 0.77 80.9
1* 48 14 28 4 0.92 0.67 0.77 0.88 80.9
5* includes all 5 Perrin technique physical signs; 4* includes postural/mechanical disturbances of the thoracic spine, tender Perrin’s 
point, tender coeliac plexus and dampened cranial flow; 3* includes postural/mechanical disturbances of the thoracic spine, tender 
Perrin’s point and tender coeliac plexus; 2* includes tender coeliac plexus and postural/mechanical disturbance of the thoracic spine; 
and 1* includes tender coeliac plexus.
the presence of postural/mechanical disturbance of the 
thoracic spine (κ=0.57; 95% CI 0.39 to 0.73, p<0.001) and 
on the presence of Perrin’s point (κ=0.56; 95% CI 0.37 
to 0.73, p<0.001). However, there was only fair agree-
ment between the AHP’s identification of the dampened 
cranial flow (κ=0.35; 95% CI 0.15 to 0.54, p=0.001), and 
there was non-significant ‘slight’ agreement on the pres-
ence of breast varicosities (κ=0.03; 95% CI −0.12 to 0.22, 
p=0.75).
diagnostic properties of alternative criteria
Given the relatively low sensitivity for the newly trained 
AHP, alternative criteria were applied using lower number 
of physical signs. Using the kappa statistics for agreement 
between the experienced and newly trained AHPs on the 
presence of the Perrin technique physical signs, each 
physical sign, in order starting with the sign with the least 
agreement, was excluded and sensitivity and specificity 
were recalculated. Overall, the AHPs were more accurate 
at diagnosing participants when using only two of the 
five signs (tender coeliac plexus and postural/mechan-
ical disturbance of the thoracic spine). Tables 3 and 4 
show the accuracy of the experienced and newly trained 
AHPs, respectively, when using each number of physical 
signs. The accuracy of the experienced AHP is the same 
using 3–5 of the physical signs (86.2%) with the highest 
accuracy using only 2 of the physical signs (88.3%). The 
accuracy of the newly trained AHP is highest using only 
one or two of the physical signs (80.9%). Therefore, 
accuracy for both AHPs, overall, is highest when using 
only tests of tender coeliac plexus and postural/mechan-
ical disturbance of the thoracic spine.
Cohen’s κ was recomputed for the level of agreement 
between the experienced and newly trained AHPs on 
whether they believed that the 94 individuals had CFS/
ME or were healthy controls, using the reduced two phys-
ical signs of the Perrin technique. There was substantial 
agreement between the two AHPs on overall diagnosis 
using the two physical signs, κ=0.61 (95% CI 0.45 to 0.74), 
p<0.001. There was no statistically significant bias in the 
diagnosis by the experienced AHP and actual diagnosis 
(p=0.55) or by the newly trained AHP and actual diag-
nosis (p=0.63) when using the reduced two-item Perrin 
technique, showing that the revised criteria no longer 
favoured a non-CFS/ME diagnosis.
dIscussIOn
Between the AHPs, the AHP with prior experience of 
using the Perrin technique was the most accurate at 
correctly diagnosing individuals with CFS/ME, whereas 
the AHP with no prior experience of CFS/ME or the 
Perrin technique was better at correctly recognising 
healthy individuals.
The AHP experienced in the Perrin technique was 
able to identify 88% of patients with CFS/ME using all 
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five physical signs and 83% of healthy controls who did 
not display all five signs. However, for the AHP with no 
prior Perrin technique experience, they were able to 
detect 86% of healthy controls but identified only 69% 
of patients with CFS/ME using all five signs; there was 
borderline non-significant evidence of this AHP underdi-
agnosing rather than overdiagnosing CFS/ME. This high-
lights that the newly trained AHP was not able to identify 
all five signs in some people with a diagnosis of CFS/ME. 
However, this does not necessarily mean that the signs 
were not present; it could mean that the newly trained 
AHP found these signs more difficult to detect. Despite 
this, there was moderate agreement between both AHPs 
on overall diagnosis.
The physician was able to correctly identify 100% of 
the healthy controls using the standard clinical neuro-
logical and rheumatological examination. However, they 
were only able to correctly identify 44% of patients with 
CFS/ME, and the tendency to underdiagnose CFS/ME 
was highly statistically significant (p<0.001). This affirms 
the current approach used in CFS diagnostics based on 
NICE guidance in that clinical examination is most useful 
in identifying alternative diagnoses and to exclude the 
diagnosis of CFS/ME, but that clinical examination is not 
a useful modality for confirming diagnosis of CFS/ME.
The agreement of the AHPs on the presence of 
each of the five physical signs varied from substan-
tial agreement on the presence of the tender coeliac 
plexus to non-significant ‘slight’ agreement on the 
presence of breast varicosities. From the results 
presented, it would seem that the physical signs 
can improve the accuracy of diagnosing CFS/ME, 
although not all of the five physical signs may be 
necessary. Even with the experienced AHP, who, 
on the whole, was able to identify the five signs, 
breast varicosities and dampened cranial flow did 
not improve accuracy of diagnosis. Further explora-
tion of the sensitivity, specificity and accuracy found 
that using only two of the five physical signs (tender 
coeliac plexus and postural/mechanical disturbance 
of the thoracic spine) was the most accurate and effi-
cient method of correctly diagnosing the participants 
for both AHPs despite their differing levels of prior 
experience of CFS/ME and the Perrin technique.
Previous work15 found Perrin’s point to have a 
diagnostic accuracy of 80% in patients with CFS/ME. 
This was very similar to the accuracy when including 
Perrin’s point in the current study (accuracy: expe-
rienced AHP=86.2% and newly trained AHP=79.8%). 
However, it was found that the omission of Perrin’s 
point marginally increased the accuracy of the AHP 
with prior experience of the Perrin technique by 
2.1% and the AHP with no prior experience of the 
Perrin technique by 1.1%.
limitations and suggestions for future research
Although this study shows clearly that diagnostic accuracy 
for CFS/ME increases using the physical signs of the Perrin 
technique, there are some limitations, which should 
be highlighted. First, this study recruited two groups of 
participants, people with a prior diagnosis of CFS/ME 
and healthy controls with no symptoms of the condition, 
as the purpose was to establish ‘proof of concept’ of the 
Perrin technique. Therefore, the study did not explore 
how accurate the Perrin technique physical signs would 
be, when presented with patients with different condi-
tions with similar presenting symptoms such as fibromy-
algia. However, in a clinical setting, knowing the history 
and symptoms together with the physical signs would help 
to differentially diagnose CFS/ME from other possible 
illnesses. Now that we have established proof-of-concept, 
it will be important to identify whether the physical signs 
of the Perrin technique, combined with history, improve 
the accuracy of identifying people with chronic fatigue 
syndrome/myalgic encephalomyelitis (CFS/ME) in clin-
ical practice.
The gender balance in the patients with CFS/ME was 
similar to that of previously published work,17 although 
the healthy volunteers were recruited as a convenience 
sample, which was not gender matched. Therefore, any 
prior knowledge of the expected male to female ratio 
among patients with CFS/ME could have influenced 
the results. It should be noted, however, that none of 
the practitioners knew if the control group was matched 
or not for gender and that the AHP with no prior expe-
rience of CFS/ME was unaware of the gender balance. 
Although all participants were aged between 18 and 60, 
individual age data were not collected for each partic-
ipant. However, it is reported that CFS/ME develops 
more commonly in those between their mid-twenties and 
mid-forties.18
Future research should investigate whether the phys-
ical signs are more apparent in people with more severe 
CFS/ME. The present study did not collect data on how 
long each participant had had CFS/ME for or on the 
severity of their symptoms, which could add further 
understanding.
Only three practitioners (one in each category) were 
used. We therefore have very limited information on 
agreement between practitioners and whether diagnostic 
accuracy is substantially affected by experience; we have 
no information on within-category variation. Future 
research should involve a study design whereby there 
are multiple experienced AHPs, newly trained AHPs and 
physicians.
A further limitation is that we selected specific symp-
toms for exclusion from the diagnostic criterion based 
on the agreement between practitioners. This was a 
pragmatic decision based on the estimated agreement 
between practitioners; it does not invalidate our find-
ings, but there may be alternative criteria that have better 
performance. Again, optimisation of the set of symptoms 
for diagnosis merits further investigation in a larger study, 
in which additional information around acceptability 
and performance of individual physical sign assessments 
could be performed.
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cOnclusIOn
Current methods for diagnosing CFS/ME are challenging. 
The use of standard clinical neurological and rheumato-
logical examination to examine illness behaviour is more 
likely to have a false negative result than a true positive 
one. Using certain physical signs appears to improve 
the accuracy of identifying people with CFS/ME and 
shows agreement with current diagnostic techniques, 
although not all of the physical signs were useful, and it is 
suggested that only two of these are needed. Examining 
for physical signs is both quick and simple for the AHP 
and may be used as an efficient screening tool for CFS/
ME. This study did not include patient/family history or 
the patient talking about their symptoms, which should 
increase accuracy in clinical practice.
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